Clinical Trial Supply Forecasting and Budgeting: A Sponsor's Guide

Key takeaways

• Clinical trial supply forecasting estimates how much product a study needs, where, and when.

• A good forecast balances two risks: running short and over supplying with waste and expiry.

• Key inputs: protocol and dosing, enrollment rate, sites and countries, lead times, and expiry.

• Forecasting connects directly to budgeting, because lead times and buffer stock drive cost.

• Forecasts are living documents and should be revisited as the study changes.

Every clinical trial runs on an estimate: how much drug, in which countries, and by when. Getting this forecast right means that sites will never run dry, whilst waste stays low. If this is miscalculated however, the sponsor is left to choose between dosing gaps and a warehouse of expiring product. Forecasting is how that estimate is made defensible.

What is clinical trial supply forecasting?

Clinical trial supply forecasting is the process of estimating the quantity, location, and timing of the investigational product comparator, and material a study needs across its lifecycle. It turns a protocol and an enrollment plan into a concrete supply plan, and it is a core part of clinical trial supply planning.

The two risks a forecast has to balance

A supply forecast is really a balance between two failure modes. Under supply leads to stockouts, dosing gaps, and emergency sourcing. Over supply leads to wasted product, expiry write offs, and unnecessary cost. The goal is not the largest possible safety net; it is the right level of cover for the study's real risk.

Key inputs to a clinical trial supply forecast

• The protocol and dosing regimen, including titration and treatment duration.

• The enrollment rate and screen fail rate, which drive real demand over time.

• The number of sites and countries, each with its own lead times and rules.

• Comparator lead times, batch availability, and expiry dates.

• The depot strategy and the re-supply triggers that keep sites stocked.

From forecast to budget

Forecasting and budgeting are two sides of the same plan. Lead times, buffer stock, expiry management, and country specific requirements all carry cost, so the forecast is where much of the supply budget is decided. Comparator strategy is a large part of that, which is why comparator drug sourcing and forecasting are best planned together rather than in sequence.

Keeping the forecast alive

A forecast made once and filed away quickly drifts from reality. Enrollment runs faster or slower than planned, sites open late, protocols amend. Revisiting the forecast on a regular cadence, and linking it to supply risk management, is what keeps a study supplied from first patient to last.

Summary and FAQ

Clinical trial supply forecasting estimates how much product a study needs, where, and when, and it balances the cost of running short against the cost of over supplying. It draws on protocol, enrollment, geography, lead times, and expiry, it feeds directly into the budget, and it works only if it is kept up to date as the study evolves.

What is clinical trial supply forecasting?

Clinical trial supply forecasting is the process of estimating how much investigational product, comparator, and material a study needs, in which locations, and at what times across the trial lifecycle.

Why is supply forecasting important?

A good forecast prevents dosing gaps caused by stockouts while avoiding the cost and waste of over supply and expiry. It keeps sites supplied without filling warehouses with product that will never be used.

What inputs drive a clinical trial supply forecast?

The main inputs are the protocol and dosing regimen, the enrollment rate and screen fail rate, the number of sites and countries, comparator lead times and expiry dates, and the depot and re-supply strategy.

How does forecasting affect the trial budget?

Forecasting and budgeting are two sides of one plan. Lead times, buffer stock, expiry management, and country specific requirements all carry cost, so the forecast directly shapes the supply budget.

How often should a supply forecast be updated?

A forecast is a living document. It should be revisited regularly as enrollment, timelines, and protocol details change, so that supply keeps pace with the study as it actually unfolds.

Want help turning your protocol into a robust supply forecast and budget? Contact CSI.

Submit your RFQ